SEC Form 4 · accession 0001144204-15-017575

DERMA SCIENCES, INC. · DSCI

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Mar 18, 2015

Accepted (ET)

Mar 20, 2015 · 5:29 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000892160

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Mar 18, 2015	M	11,250	$3.36	A	53,500	D
Common Stock^F1	Mar 18, 2015	F	4,604	$8.21	D	48,896	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy)^F3,F2	$3.36	Mar 18, 2015	M	11,250	D	May 12, 2005	May 12, 2015	Common Stock	11,250	0	D

F1Shares delivered in connection with the cashless exercise of 11,250 options, previously granted pursuant to the issuer's stock option plan, at an exercise price of $3.36, as reported herein.
F2A total of 90,000 of the options were granted pursuant to the issuer's stock option plan, which vested as to 60,000 shares on May 25, 2005, the date of the execution of the stock option agreement reflecting the grant, and vested as to an additional 10,000 shares on May 25 of 2006, 2007 and 2008. The revised total of 11,250 options reflects the issuer's 1-for-8 reverse split effective January 1, 2010.
F3The options were originally issued in consideration of the reporting person's services to the issuer and without payment of cash consideration, under the issuer's stock option plan.